Leo Beletsky, JD, MPH
Professor
Department of Health Sciences, Faculty, School of Law
Office: 120 KN
Email: [email protected]
Phone: 617.373.5540
Professor
Department of Health Sciences, Faculty, School of Law
Office: 120 KN
Email: [email protected]
Phone: 617.373.5540
Leo Beletsky’s expertise is in the public health impact of laws and their enforcement, with a special focus on drug overdose, infectious disease transmission, and criminal justice reform through a public health lens. Throughout his career, Professor Beletsky has applied his skills and expertise in service to governmental agencies and non-governmental organizations, including the United Nations, The Pew Charitable Trusts, and the City of New York.
Education/degrees:
JD: Temple University
MPH: Brown University
Post-doctoral training: Yale University
Institutional Affiliations & Appointments
Director, Health in Justice Action Lab
Faculty Scholar, Institute for Health Equity and Social Justice Research
Associate Adjunct Professor at the UC San Diego School of Medicine
Fellow, Justice Collaborative Institute
Research Interests:
Social Epidemiology of Law and its Enforcement, Public Health Law, Overdose Prevention, Infectious Disease Prevention, Structural Determinants of Health
Courses:
Global Health
Selected Recent Publications:
Beletsky L, Wakeman SE, and Fiscella K. Practicing What We Preach – Ending Physician Health Program Bans on Opioid-Agonist Therapy. New England Journal of Medicine 2019; 381(9):796-797.
Arredondo J, Beletsky L (joint first authors), Baker P, Abramovitz D, Artamonova I, Clairgue E, Morales M, Mittal ML, Rocha-Jimenez T, Kerr T, Banuelos A, Strathdee SA, and Cepeda J. Interactive Versus Video-Based Training of Police to Communicate Syringe Legality to People Who Inject Drugs: The SHIELD Study, Mexico, 2015–2016. American Journal of Public Health 2019; 109(6): 921-926.
Beletsky L, Baker P, Arredondo J, Emuka A, Goodman-Meza D, Medina-Mora ME, Werb D, Davidson P, Amon JJ, Strathdee SA and Magis-Rodriguez C. The global health and equity imperative for safe consumption facilities. The Lancet 2018; 392(10147):553-4
Fiscella K, Wakeman SE, and Beletsky, L. X the X-Waiver: Buprenorphine Deregulation and Mainstreaming Treatment for Opioid Use Disorder. Journal of the American Medical Association Psychiatry 2018; doi: 10.1001/jamapsychiatry.2018.3685.
Dasgupta N, Beletsky L (joint first authors), Ciccarone D. Opioid Crisis: No Easy Fix to Its Social and Economic Determinants. American Journal of Public Health. 108(2):182-186.
Selected Public Service:
Fellow, Justice Collaborative Institute
Expert Group Member, The Global Fund to Fight AIDS, Tuberculosis, and Malaria
Consultant, Pew Charitable Trusts
Website